SCHEMBL2339919

SCHEMBL2339919

C1=NC2=NNNC2=c2ccccc2=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7353184 0.53
SCHEMBL6293154 0.48 MAPT (0.30)
SCHEMBL8121239 0.48
Ethylene SCHEMBL8984236 0.47 ALOX12 (0.39)
SCHEMBL5888763 0.47
SCHEMBL26612937 0.47 ALOX12 (0.39)
Ethylene SCHEMBL27715093 0.47 ALOX12 (0.39)
SCHEMBL747701 0.46
SCHEMBL58153 0.46 ALOX12 (0.46)
SCHEMBL29061457 0.46 ALOX12 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11033601-B2 Selective inhibition of V1b for treating fatty liver THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-06-15 US disclosed
US-20190083568-A1 SELECTIVE INHIBITION OF V1b AND/OR STABILIZATION OR UPREGULATION OF V1a FOR TREATING FATTY LIVER REGENTS OF THE UNIVERSITY OF COLORADO, A BODY COPORATE 2019-03-21 US disclosed
CN-102227428-B Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists HOFFMANN LA ROCHE 2015-03-25 CN disclosed
CN-102227428-B Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists HOFFMANN LA ROCHE 2015-03-25 CN disclosed
CN-102216304-B Alkylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN LA ROCHE 2014-07-09 CN disclosed
CN-102216304-B Alkylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN LA ROCHE 2014-07-09 CN disclosed
US-8642590-B2 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2014-02-04 US disclosed
US-8642590-B2 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2014-02-04 US disclosed
US-8642590-B2 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2014-02-04 US disclosed
EP-2370441-B1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2013-09-11 EP disclosed
EP-2358714-A1 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES F. Hoffmann-La Roche AG (CH) 2011-08-24 EP disclosed
EP-2358714-A1 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES F. Hoffmann-La Roche AG (CH) 2011-08-24 EP disclosed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO disclosed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO disclosed
US-20100137286-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES HOFFMANN-LA ROCHE, INC. 2010-06-03 US disclosed
US-20100137286-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES HOFFMANN-LA ROCHE, INC. 2010-06-03 US disclosed
WO-2010057795-A1 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES F. HOFFMANN-LA ROCHE AG (CH) 2010-05-27 WO disclosed
WO-2010057795-A1 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES F. HOFFMANN-LA ROCHE AG (CH) 2010-05-27 WO disclosed
US-20100125066-A1 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES F. HOFFMANN-LA ROCHE AG (CH) 2010-05-20 US disclosed
US-20100125066-A1 ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES F. HOFFMANN-LA ROCHE AG (CH) 2010-05-20 US disclosed